I didn't know they had completed the trial design for the Psilocybin - General Anxiety Disorder trial... did you?
Next steps for that will be very exciting, and the US market will pay close attention to that progress when US listing occurs. The next update for that pathway could be quite price sensitive for the US market.
US Listing, page-45
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)